Meiragtx Holdings PLC - (MGTX) closed at $8.74 on November 16, 2026, down 4.8% from the previous close, on volume of 665,852 shares (30-day average 722,048).
Data as of November 16, 2026.
16-Nov-2026
MeiraGTx Announces Oral Presentation at ObesityWeek 2026
Globe Newswire (Mon, 16-Nov 7:00 AM ET)
Bank of America Securities Reaffirms Their Buy Rating on Meiragtx Holdings (MGTX)
TipRanks (Fri, 13-Nov 10:55 AM ET)
H.C. Wainwright Keeps Their Buy Rating on Meiragtx Holdings (MGTX)
TipRanks (Fri, 13-Nov 9:39 AM ET)
Meiragtx Holdings (MGTX) Receives a Buy from RBC Capital
TipRanks (Fri, 13-Nov 9:39 AM ET)
MeiraGTx GAAP EPS of -$0.53 misses by $0.03, revenue of $4.81M misses by $2.21M
Seeking Alpha News (Thu, 12-Nov 8:15 AM ET)
MeiraGTx Reports Third Quarter 2026 Financial and Operational Results
Globe Newswire (Thu, 12-Nov 8:00 AM ET)
Globe Newswire (Tue, 27-Oct 8:00 AM ET)
MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors
Globe Newswire (Wed, 23-Sep 8:00 AM ET)
PRNewswire (Wed, 26-Aug 10:51 AM ET)
Market Chameleon (Tue, 7-Jul 3:50 AM ET)
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Meiragtx Holdings PLC - trades on the NASDAQ stock market under the symbol MGTX.
As of November 16, 2026, MGTX stock price declined to $8.74 with 665,852 million shares trading.
MGTX has a beta of 2.07, meaning it tends to be more sensitive to market movements. MGTX has a correlation of 0.20 to the broad based SPY ETF.
MGTX has a market cap of $854.16 million. This is considered a Small Cap stock.
Last quarter Meiragtx Holdings PLC - reported $5 million in Revenue and -$.53 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.06.
In the last 3 years, MGTX traded as high as $15.35 and as low as $3.85.
The top ETF exchange traded funds that MGTX belongs to (by Net Assets): IWM, FYC, IBB, IWO, VTWO.
MGTX has underperformed the market in the last year with a price return of +6.7% while the SPY ETF gained +11.3%. MGTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -35.4% and -6.2%, respectively, while the SPY returned -4.4% and -1.6%, respectively.
MGTX support price is $8.80 and resistance is $9.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MGTX shares will trade within this expected range on the day.